Treatment with the targeted therapy drug crizotinib effectively halted the growth of lung tumors driven by rearrangements of the ROS1 gene in a small clinical trial.
from Latest Science News -- ScienceDaily http://ift.tt/YEVvhw
from Latest Science News -- ScienceDaily http://ift.tt/YEVvhw
0 commentaires:
Enregistrer un commentaire